Predominance of D2 receptors in mediating dopamine's effects in brain metabolism: Effects of alcoholism

Journal of Neuroscience

Volumn 33, Issue 10, 2013, Pages 4527-4535

  Volkow, Nora D ^a,b   Tomasi, Dardo ^b   Wang, Gene Jack ^c   Telang, Frank ^a   Fowler, Joanna S ^c   Logan, Jean ^c   Jayne Maynard, L ^a   Wong, Christopher T ^a  

^a NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

^b NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM   (United States)

^c BROOKHAVEN NATIONAL LABORATORY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOPAMINE; DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; METHYLPHENIDATE; RACLOPRIDE C 11;

ADULT; ALCOHOLISM; AMYGDALOID NUCLEUS; ANTERIOR CINGULATE; ARTICLE; BEHAVIOR CHANGE; BRAIN METABOLISM; CARDIOVASCULAR DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; GLUCOSE METABOLISM; HUMAN; MALE; ORBITAL CORTEX; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SUBTHALAMIC NUCLEUS;

ADULT; ALCOHOLISM; ANALYSIS OF VARIANCE; BRAIN; BRAIN MAPPING; CARBON RADIOISOTOPES; CARDIOVASCULAR PHYSIOLOGICAL PROCESSES; DOPAMINE; DOPAMINE ANTAGONISTS; DOPAMINE UPTAKE INHIBITORS; FLUORODEOXYGLUCOSE F18; HUMANS; MALE; METHYLPHENIDATE; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY; RACLOPRIDE; RECEPTORS, DOPAMINE D2; REGRESSION ANALYSIS; TIME FACTORS;

EID: 84874617644     PISSN: 02706474     EISSN: 15292401     Source Type: Journal    
DOI: 10.1523/JNEUROSCI.5261-12.2013     Document Type: Article

References (56)

1. Behar KL, Rothman DL, Petersen KF, Hooten M, Delaney R, Petroff OA, Shulman GI, Navarro V, Petrakis IL, Charney DS, Krystal JH (1999) Preliminary evidence of low cortical GABA levels in localized 1H-MR spectra of alcohol-dependent and hepatic encephalopathy patients. Am J Psychiatry 156:952-954. Medline
2. Breiter HC, Gollub RL, Weisskoff RM, Kennedy DN, Makris N, Berke JD, Goodman JM, Kantor HL, Gastfriend DR, Riorden JP, Mathew RT, Rosen BR, Hyman SE (1997) Acute effects of cocaine on human brain activity and emotion. Neuron 19:591-611. CrossRef Medline
3. Casanova R, Srikanth R, Baer A, Laurienti PJ, Burdette JH, Hayasaka S, Flowers L, Wood F, Maldjian JA (2007) Biological parametric mapping: aA statistical toolbox for multimodality brain image analysis. Neuroimage 34:137-143. CrossRef Medline
4. Friston K, Holmes AP, Worsley KJ, Poline JB, Frith CD, Frackowiak RSJ (1995) Statistical parametric maps in functional imaging: a general linear approach. Hum Brain Mapp 2:189-210.
5. Girault JA, Greengard P (2004) The neurobiology of dopamine signaling. Arch Neurol 61:641-644. CrossRef Medline
6. Glantz S (2002) Primer of Biostatistics Statistical Software Program CD-ROM. New York: McGraw-Hill.
7. Gorelova N, Seamans JK, Yang CR (2002) Mechanisms of dopamine activation of fast-spiking interneurons that exert inhibition in rat prefrontal cortex. J Neurophysiol 88:3150-3166. CrossRef Medline
8. Hamilton M (1960) A rating scale for depression. J Neurol Neurosurg Psychiatry 23:56-62. CrossRef Medline
9. Koob GF, Bloom FE (1988) Cellular and molecular mechanisms of drug dependence. Science 242:715-723. CrossRef Medline
10. Kufahl PR, Li Z, Risinger RC, Rainey CJ, Wu G, Bloom AS, Li SJ (2005) Neural responses to acute cocaine administration in the human brain detected by fMRI. Neuroimage 28:904-914. CrossRef Medline
11. Kufahl P, Li Z, Risinger R, Rainey C, Piacentine L, Wu G, Bloom A, Yang Z, Li SJ (2008) Expectation modulates human brain responses to acute cocaine: a functional magnetic resonance imaging study. Biol Psychiatry 63:222-230. CrossRef Medline
12. Kumar S, Porcu P, Werner DF, Matthews DB, Diaz-Granados JL, Helfand RS, Morrow AL (2009) The role of GABA(A) receptors in the acute and chronic effects of ethanol: a decade of progress. Psychopharmacology (Berl) 205:529-564. CrossRef Medline
13. Lingford-Hughes AR, Acton PD, Gacinovic S, Suckling J, Busatto GF, Boddington SJ, Bullmore E, Woodruff PW, Costa DC, Pilowsky LS, Ell PJ, Marshall EJ, Kerwin RW (1998) Reduced levels of GABAbenzodiazepine receptor in alcohol dependency in the absence of grey matter atrophy. Br J Psychiatry 173:116-122. CrossRef Medline
14. Logan J, Fowler JS, Volkow ND, Wolf AP, Dewey SL, Schlyer DJ, MacGregor RR, Hitzemann R, Bendriem B, Gatley SJ (1990) Graphical analysis of reversible radioligand binding from time-activity measurements applied to [N-11C-methyl]-(-)-cocaine PET studies in human subjects. J Cereb Blood Flow Metab 10:740-747. CrossRef Medline
15. Lyons D, Friedman DP, Nader MA, Porrino LJ (1996) Cocaine alters cerebral metabolism within the ventral striatum and limbic cortex of monkeys. J Neurosci 16:1230-1238. Medline
16. Makris N, Oscar-Berman M, Jaffin SK, Hodge SM, Kennedy DN, Caviness VS, Marinkovic K, Breiter HC, Gasic GP, Harris GJ (2008) Decreased volume of the brain reward system in alcoholism. Biol Psychiatry 64:192-202.
17. Mandeville JB, Choi JK, Jarraya B, Rosen BR, Jenkins BG, VanduffelW (2011) fMRI of cocaine self-administration in macaques reveals functional inhibition of basal ganglia. Neuropsychopharmacology 36:1187-1198. CrossRef Medline
18. Mukherjee J, Christian BT, Narayanan TK, Shi B, Collins D (2005) Measurement of d-amphetamine-induced effects on the binding of dopamine D-2/D-3 receptor radioligand, 18F-fallypride in extrastriatal brain regions in non-human primates using PET. Brain Res 1032:77-84. CrossRef Medline
19. Narendran R, Frankle WG, Mason NS, Rabiner EA, Gunn RN, Searle GE, Vora S, Litschge M, Kendro S, Cooper TB, Mathis CA, Laruelle M (2009) Positron emission tomography imaging of amphetamine-induced dopamine release in the human cortex: a comparative evaluation of the high affinity dopamine D2/D3 radiotracers [11C]FLB 457 and [11C]fallypride. Synapse 63:447-461. CrossRef Medline
20. Nishikawa M, Diksic M, Sakai Y, Kumano H, Charney D, Palacios-Boix J, Negrete J, Gill K (2009) Alterations in brain serotonin synthesis in male alcoholics measured using positron emission tomography. Alcohol Clin Exp Res 33:233-239. CrossRef Medline
21. Patrick K, Markowitz J (1997) Pharmacology of methylphenidate, amphetamine enantiomers and pemoline in attention-deficit hyperactivity disorder. Hum Psychopharmacol 12:527-546. CrossRef
22. Pavese N, Andrews TC, Brooks DJ, Ho AK, Rosser AE, Barker RA, Robbins TW, Sahakian BJ, Dunnett SB, Piccini P (2003) Progressive striatal and cortical dopamine receptor dysfunction in Huntington's disease: a PET study. Brain 126:1127-1135. CrossRef Medline
23. Pavese N, Politis M, Tai YF, Barker RA, Tabrizi SJ, Mason SL, Brooks DJ, Piccini P (2010) Cortical dopamine dysfunction in symptomatic and premanifest Huntington's disease gene carriers. Neurobiol Dis 37:356-361. CrossRef Medline
24. Phelps ME, Huang SC, Hoffman EJ, Selin C, Sokoloff L, Kuhl DE (1979) Tomographic measurement of local cerebral glucose metabolic rate in humans with (F-18)2-fluoro-2-deoxy-D-glucose: validation of method. Ann Neurol 6:371-388. CrossRef Medline
25. Politis M, Pavese N, Tai YF, Kiferle L, Mason SL, Brooks DJ, Tabrizi SJ, Barker RA, Piccini P (2011) Microglial activation in regions related to cognitive function predicts disease onset in Huntington's disease: a multimodal imaging study. Hum Brain Mapp 32:258-270. CrossRef Medline
26. Ribeiro MJ, Thobois S, Lohmann E, du Montcel ST, Lesage S, Pelissolo A, Dubois B, Mallet L, Pollak P, Agid Y, Broussolle E, Brice A, Remy P (2009) A multitracer dopaminergic PET study of young-onset parkinsonian patients with and without parkin gene mutations. J Nucl Med 50: 1244-1250. CrossRef Medline
27. Riccardi P, Li R, Ansari MS, Zald D, Park S, Dawant B, Anderson S, Doop M, Woodward N, Schoenberg E, Schmidt D, Baldwin R, Kessler R (2006) Amphetamine-induced displacement of [18F] fallypride in striatum and extrastriatal regions in humans. Neuropsychopharmacology 31:1016-1026. CrossRef Medline
28. Ridge JP, Ho AM, Innes DJ, Dodd PR (2008) The expression of NMDA receptor subunit mRNA in human chronic alcoholics. Ann N Y Acad Sci 1139:10-19. CrossRef Medline
29. Risinger RC, Salmeron BJ, Ross TJ, Amen SL, Sanfilipo M, Hoffmann RG, Bloom AS, Garavan H, Stein EA (2005) Neural correlates of high and craving during cocaine self-administration using BOLD fMRI. Neuroimage 26:1097-1108. CrossRef Medline
30. Sawamoto N, Piccini P, Hotton G, Pavese N, Thielemans K, Brooks DJ (2008) Cognitive deficits and striato-frontal dopamine release in Parkinson's disease. Brain 131:1294-1302. CrossRef Medline
31. Schwartz WJ, Smith CB, Davidsen L, Savaki H, Sokoloff L, Mata M, Fink DJ, Gainer H (1979) Metabolic mapping of functional activity in the hypothalamo-neurohypophysial system of the rat. Science 205:723-725. CrossRef Medline
32. Shotbolt P, Tziortzi AC, Searle GE, Colasanti A, van der Aart J, Abanades S, Plisson C, Miller SR, Huiban M, Beaver JD, Gunn RN, Laruelle M, Rabiner EA (2012) Within-subject comparison of [(11)C]-(-)-PHNO and [(11)C]raclopride sensitivity to acute amphetamine challenge in healthy humans. J Cereb Blood Flow Metab 32:127-136. CrossRef Medline
33. Slifstein M, Kegeles LS, Xu X, Thompson JL, Urban N, Castrillon J, Hackett E, Bae SA, Laruelle M, Abi-Dargham A (2010) Striatal and extrastriatal dopamine release measured with PET and [(18)F] fallypride. Synapse 64:350-362. CrossRef Medline
34. 14C]deoxyglucose method for the measurement of local cerebral glucose utilization: theory, procedure, and normal values in the conscious and anesthetized albino rat. J Neurochem 28:897-916. CrossRef Medline
35. Srinivas NR, Hubbard JW, Quinn D, Korchinski ED, Midha KK (1991) Extensive and enantioselective presystemic metabolism of dl-threomethylphenidate in humans. Prog Neuropsychopharmacol Biol Psychiatry 15:213-220. CrossRef Medline
36. Stokes PR, Egerton A, Watson B, Reid A, Breen G, Lingford-Hughes A, Nutt DJ, Mehta MA (2010) Significant decreases in frontal and temporal [11C]- raclopride binding after THC challenge. Neuroimage 52:1521-1527. CrossRef Medline
37. Suzuki M, Hurd YL, Sokoloff P, Schwartz JC, Sedvall G (1998) D3 dopamine receptor mRNA is widely expressed in the human brain. Brain Res 779:58-74. CrossRef Medline
38. Treadway MT, Buckholtz JW, Cowan RL, Woodward ND, Li R, Ansari MS, Baldwin RM, Schwartzman AN, Kessler RM, Zald DH (2012) Dopaminergic mechanisms of individual differences in human effort-based decision-making. J Neurosci 32:6170-6176. CrossRef Medline
39. Tupala E, Hall H, Mantere T, Rasanen P, Sarkioja T, Tiihonen J (2003) Dopamine receptors and transporters in the brain reward circuits of type 1 and 2 alcoholics measured with human whole hemisphere autoradiography. Neuroimage 19:145-155. CrossRef Medline
40. Van Essen DC, Glasser MF, Dierker DL, Harwell J, Coalson T (2012) Parcellations and hemispheric asymmetries of human cerebral cortex analyzed on surface-based atlases. Cereb Cortex 22:2241-2262. CrossRef Medline
41. Volkow ND, Wang GJ, Hitzemann R, Fowler JS, Wolf AP, Pappas N, Biegon A, Dewey SL (1993a) Decreased cerebral response to inhibitory neurotransmission in alcoholics. Am J Psychiatry 150:417-422. Medline
42. Volkow ND, Fowler JS, Wang GJ, Dewey SL, Schlyer D, MacGregor R, Logan J, Alexoff D, Shea C, Hitzemann R (1993b) Reproducibility of repeated measures of carbon-11-raclopride binding in the human brain. J Nucl Med 34:609-613. Medline
43. Volkow ND, Wang GJ, Fowler JS, Logan J, Schlyer D, Hitzemann R, Lieberman J, Angrist B, Pappas N, MacGregor R (1994) Imaging endogenous dopamine competition with [11C]raclopride in the human brain. Synapse 16:255-262. CrossRef Medline
44. Volkow ND, Ding YS, Fowler JS, Wang GJ, Logan J, Gatley JS, Dewey S, Ashby C, Liebermann J, Hitzemann R (1995) Is methylphenidate like cocaine? Studies on their pharmacokinetics and distribution in the human brain. Arch Gen Psychiatry 52:456-463. CrossRef Medline
45. Volkow ND, Wang GJ, Fowler JS, Logan J, Angrist B, Hitzemann R, Lieberman J, Pappas N (1997) Effects of methylphenidate on regional brain glucose metabolism in humans: relationship to dopamine D2 receptors. Am J Psychiatry 154:50-55. Medline
46. Volkow ND, Wang GJ, Fowler JS, Gatley SJ, Logan J, Ding YS, Hitzemann R, Pappas N (1998) Dopamine transporter occupancies in the human brain induced by therapeutic doses of oral methylphenidate. Am J Psychiatry 155:1325-1331. Medline
47. Volkow ND, Wang GJ, Fowler JS, Logan J, Franceschi D, Maynard L, Ding YS, Gatley SJ, Gifford A, Zhu W, Swanson JM (2002) Relationship between blockade of dopamine transporters by oral methylphenidate and the increases in extracellular dopamine: therapeutic implications. Synapse 43: 181-187. CrossRef Medline
48. Volkow ND, Wang GJ, Ma Y, Fowler JS, Zhu W, Maynard L, Telang F, Vaska P, Ding YS, Wong C, Swanson JM (2003) Expectation enhances the regional brain metabolic and the reinforcing effects of stimulants in cocaine abusers. J Neurosci 23:11461-11468. Medline
49. Volkow ND, Wang GJ, Telang F, Fowler JS, Logan J, Jayne M, Ma Y, Pradhan K, Wong C (2007a) Profound decreases in dopamine release in striatum in detoxified alcoholics: possible orbitofrontal involvement. J Neurosci 27:12700-12706. CrossRef Medline
50. Volkow ND, Wang GJ, Newcorn J, Telang F, Solanto MV, Fowler JS, Logan J, Ma Y, Schulz K, Pradhan K, Wong C, Swanson JM (2007b) Depressed dopamine activity in caudate and preliminary evidence of limbic involvement in adults with attention-deficit/hyperactivity disorder. Arch Gen Psychiatry 64:932-940. CrossRef Medline
51. Volkow ND, Wang GJ, Fowler JS, Tomasi D (2012) Addiction circuitry in the human brain. Annu Rev Pharmacol Toxicol 52:321-336. CrossRef Medline
52. Wang GJ, Volkow ND, Roque CT, Cestaro VL, Hitzemann RJ, Cantos EL, Levy AV, Dhawan AP (1993) Functional importance of ventricular enlargement and cortical atrophy in healthy subjects and alcoholics as assessed with PET, MR imaging, and neuropsychologic testing. Radiology 186:59-65. Medline
53. Wang GJ, Volkow ND, Hitzemann RJ, Wong C, Angrist B, Burr G, Pascani K, Pappas N, Lu A, Cooper T, Ja L (1997) Behavioral and cardiovascular effects of intravenous methylphenidate in normal subjects and cocaine abusers. Eur Addict Res 3:49-54. CrossRef
54. Wang GJ, Volkow ND, Fowler JS, Logan J, Pappas NR, Wong CT, Hitzemann RJ, Netusil N (1999) Reproducibility of repeated measures of endogenous dopamine competition with [11C]raclopride in the human brain in response to methylphenidate. J Nucl Med 40:1285-1291. Medline
55. Wang GJ, Smith L, Volkow ND, Telang F, Logan J, Tomasi D, Wong CT, Hoffman W, Jayne M, Alia-Klein N, Thanos P, Fowler JS (2012) Decreased dopamine activity predicts relapse in methamphetamine abusers. Mol Psychiatry 17:918-925. CrossRef Medline
56. West AR, Grace AA (2002) Opposite influences of endogenous dopamine D1 and D2 receptor activation on activity states and electrophysiological properties of striatal neurons: studies combining in vivo intracellular recordings and reverse microdialysis. J Neurosci 22:294-304. Medline